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Abstract
Background: A disturbance in the immune system has been described in Turner syndrome
(45,X), with an association to low levels of IgG and IgM and decreased levels of T- and B-
lymphocytes. Also different autoimmune diseases have been connected to Turner syndrome
(45,X), thyroiditis being the most common. Other autoimmune diseases seen are inflammatory
bowel disease, insulin dependent diabetes mellitus, Addison's disease, rheumatoid arthritis,
myasthenia gravis, vitiligo, alopecia, pernicious anaemia and hypoparathyroidism, but the
association to Turner syndrome is not definite.
Besides the typical features of Turner syndrome (short stature, failure to enter puberty
spontaneously and infertility due to ovarian insufficiency) ear problems are common. Otitis media
and a progressive sensorineural hearing disorder are commonly seen. In the normal population
there are known inner ear disorders related to autoimmune diseases. The aim of this study was to
investigate patients with Turner syndrome regarding autoantibodies connected to the autoimmune
disorders; autoimmune polyendocrine syndrome type I and II and Addison's disease, to screen for
overlapping profile of autoantibodies.
Blood samples from 110 Turner patients (7–65 years) were investigated using in vitro transcription,
translation and immunoprecipitation techniques regarding autoantibodies connected to
autoimmune polyendocrine syndrome type I and II and Addison's disease (21-hydroxylase, 17α-
hydroxylase, side-chain cleavage enzyme, aromatic L-amino acid decarboxylase, tyrosine
hydroxylase and tryptophan hydroxylase).
Results: The autoantibodies investigated were not overrepresented among the Turner patients.
Conclusion: The autoimmune disorders associated with Turner syndrome do not seem to be of
the same origin as Addison's disease, the type I or II autoimmune polyendocrine syndrome.
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Background
Turner syndrome is caused by the presence of only one
normally functioning X-chromosome. The other sex chro-
mosome can be missing (45,X) or abnormal and mosai-
cism is often present. Occurring in one of every 2000
female births, Turner syndrome is one of our most com-
mon sex chromosome abnormalities [1]. Turner syn-
drome is characterized by short stature, no spontaneous
puberty and infertility due to ovarian dysgenesis [2].
Besides the typical features of Turner syndrome ear prob-
lems are common. During childhood the girls repeatedly
suffer from otitis media and a progressive sensorineural
hearing disorder is commonly seen [3-6].
Immunological disturbances have previously been
described in Turner syndrome, with an association to
reduced levels of serum IgG and IgM, increased IgA and
decreased levels of circulating T- and B-lymphocytes.
However the results have not been conclusive [6-9].
Also different autoimmune diseases have been connected
to Turner syndrome. An increased incidence of anti-thy-
roid antibodies has repeatedly been reported and thyroid
dysfunctions are common [2,10-12]. Other autoimmune
diseases described are inflammatory bowel disease, insu-
lin dependent diabetes mellitus (IDDM), Addison's dis-
ease, rheumatoid arthritis, myasthenia gravis, vitiligo,
alopecia, pernicious anaemia and hypoparathyroidism,
but the association to Turner syndrome is not definite
[10].
Normally Addison's disease is often associated with other
autoimmune diseases, such as thyroiditis, IDDM, prema-
ture ovarian failure (POF), vitiligo and hypoparathy-
roidism. Addison's disease may be present as an isolated
disorder or part of type I or II autoimmune polyendocrine
syndrome (APS I or APS II), where also pernicious anae-
mia, gastrointestinal dysfunctions, alopecia and chronic
candidiasis are common [13]. Several autoantigens have
been identified to be connected to these three disorders as
illustrated in table 1[13-18]. Autoimmune inner ear dis-
ease is a multifactorial disorder that lately has been dis-
cussed. These patients often present autoantibodies or
cellular factors, directed against several inner ear struc-
tures, but the etiology is still not completely characterized
[19-21]. Of the autoantibodies seen in APS I, tyrosine
hydroxylase (TH) could be a possible cochlear autoanti-
gen, as it has been proposed as potential melanin catalyser
in the inner ear [22]. Some inner ear diseases are known
to be caused by water and ion regulating problems, which
is the case with Addison's disease.
The aim of this study was to investigate girls and women
with Turner syndrome regarding autoantibodies con-
nected to the autoimmune disorders APS 1, APS II and
Addison's disease, to screen for overlapping profile of
autoantibodies.
Results
Autoantibodies in Turner women
No autoantibodies to 21-hydroxylase (21-OH), 17α-
hydroxylase (17-OH), side-chain cleavage enzyme (SCC),
aromatic L-amino acid decarboxylase (AADC) were
detected among the Turner women (N = 110). However,
one Turner woman presented autoantibodies to tryp-
tophan hydroxylase (TPH) and two to tyrosine hydroxy-
lase (TH).
Table 1: 
Disease Antigen Enzyme action
Addison's disease 21-Hydroxylase (21-OH) Steroid hormone synthesis
Addison's disease with POF 21-Hydroxylase (21-OH) Steroid hormone synthesis
Side-chain cleavage enzyme (SCC) Steroid hormone synthesis
APS I 17α-hydroxylase (17α-OH) Steroid hormone synthesis
Aromatic L-amino acid decarboxylase (AADC) Monoaminergic and serotonergic biosynthetic pathways
Tyrosine hydroxylase (TH) Rate-limiting enzyme in catecholamine biosynthesis
Tryptophan hydroxylase (TPH) Rate limiting enzyme in the synthesis of serotonin
APS II 21-Hydroxylase (21-OH) Steroid hormone synthesis
Description of important autoantigens in Addison's disease, Addison's disease with premature ovarian failure (POF), APS I and APS II. Patients with 
Addison's disease generally display autoantibodies to the enzyme 21-OH restricted to the adrenal cortex, while most of the patients with APS I 
show autoantibodies to SCC, located both in the adrenal cortex and steroid producing cells in the gonads, reflecting the risk of developing ovarian 
failure. In addition patients with Addison's disease and POF, also show antibodies directed against SCC (13). TPH is found as an intestinal 
autoantigen in APS I patients with intestinal dysfunction (14) and TH autoantibodies are correlated to alopecia areata in these patients (15).Journal of Negative Results in BioMedicine 2007, 6:10 http://www.jnrbm.com/content/6/1/10
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Except for 3 blood donors having low titers of antibodies
to TH, none of the 40 blood donors showed any positive
autoantibody titers.
Antibodies to thyroid peroxidase (TPO) were recorded in
40% (36/91) of the Turner women analyzed, and of these
50% had hypothyroidism. Of the women who were posi-
tive to anti-TPO, only 6 showed a hearing loss, as com-
pared 16 women in the group negative to anti-TPO.
Discussion
When screening for autoantibodies the only autoantibody
overrepresented was that against TPO (40%), correlating
to an increased incidence of thyroid dysfunctions among
the Turner patients. This is in concordance with previ-
ously described prevalence of thyroiditis (20–50%). How-
ever in earlier studies even higher prevalence of anti-
thyroid autoantibodies (50–85%) has been observed
[10]. This discrepancy could depend on differences in
patient selection and/or methods. There is a known con-
nection between hypothyroidism and hearing dysfunc-
tion [23]. However, hearing loss was not over represented
in the group with anti-TPO antibodies.
Considering that many of the autoimmune diseases doc-
umented in Turner syndrome [10-12] also are seen in APS
I and APS II, one could imagine an overlapping autoanti-
body profile. In this study the only autoantibodies found
in Turner syndrome were directed against TH and TPH, in
two respectively one woman with Turner syndrome. TH
autoantibodies were also found in a few healthy blood
donors. Antibodies to 21-OH, the most important
autoantigen in Addison's disease [13], were not registered
in any of the women with Turner syndrome, which is in
line with that none of the examined patients presented
any symptoms of Addison's disease. Only a few other
autoimmune diseases were present in the group of Turner
patient (see materials and methods), however these data
were obtained through the medical history. Consequently
a putative relation between Turner syndrome and the
autoimmunity seen in APS I or APS II seems weak.
Turner females have a progressive hearing loss, both in the
midfrequencies and also in the high frequencies [3,4],
why an autoimmune situation could be suspected. In this
study the only potential cochlear antigen investigated was
TH. As TH autoantibodies were found only in two
patients, not correlating to a hearing disability, TH does
not appear to be an autoantigen connected to the sen-
sorineural hearing loss seen in Turner syndrome. One
hypothesis, put forward by Barrenäs et al., is that the ear
and hearing problems are correlated to the degree of X
chromosome loss, leading to growth disturbances during
fetal life [24]. An additional theory discussed is that the
age dependent sensorineural hearing impairment may be
enhanced because of the lack of estrogens [25].
Conclusion
In conclusion the autoimmune disorders sometimes asso-
ciated with Turner syndrome do not seem to be of the
same origin as Addison's disease, APS I or APS II.
Methods
Subjects
Blood samples from patients with the diagnosis Turner
syndrome, genetically confirmed, were investigated
according to the Swedish ethical record no 88–265.
The patients consisted of 110 girls and women with
Turner syndrome in the Stockholm area aged 7–65 years
(median age 33 years). Autoimmune diseases present in
women older than 18 years (n = 97) were thyroid dysfunc-
tion (23%), celiac disease (4%), inflammatory bowel dis-
ease (3%), diabetes melittus (IDDM) (3%), and Vitiligo
(1%). The karyotypes of the patients were: 45,X (51%),
45,X/46,XX (23%), 45,X/46,XY (3%), 45,X/46,XX/47,XXX
(3%), 45,X/46,X,i(Xq) (18%) and 45,X/46,X,r(X) (3%) (r
= ring chromosome). In the group 45,X/46,XX the karyo-
types 45,X/46,X,del(X)(q11) (del = deletion) and 45,X/
46,XXq+ were included. Forty healthy sex and age
matched blood donors served as controls.
A medical history was attained, focusing on autoimmune
diseases, previous and current ear diseases, ear operations
and hearing problems. A clinical investigation of the Ear-
Nose and Throat area was also performed.
In vitro transcription and translation and 
immunoprecipitation
Autoantibodies to 21-hydroxylase (21-OH), 17α-hydrox-
ylase (17-OH), side-chain cleavage enzyme (SCC), aro-
matic L-amino acid decarboxylase (AADC), tyrosine
hydroxylase (TH) and tryptophan hydroxylase (TPH)
were analysed as follows:
In vitro transcription and translation and immunoprecipitation
Plasmids, containing cDNA of the antigens were purified
with Qiagen miniprep kit (Qiagen GmbH, Hilden, Ger-
many). The construction of the plasmids has been pub-
lished elsewhere [14-18]. In vitro transcription and
translation of the purified plasmids were performed using
the TNT SP6 and T3-coupled reticulocyte lysate system
(Promega). The correct size of the radioactive product was
analyzed on a SDS-PAGE minigel (BioRad, Richmond,
CA) according to standard protocols. Each [35S]-radiola-
beled protein (21-OH, 17-OH, SCC, AADC, TH and TPH)
was used for immunoprecipitation with patient sera in a
96-wells plate assay as described elsewhere [14-18]. The
results were expressed as index ((sample - cpm negativeJournal of Negative Results in BioMedicine 2007, 6:10 http://www.jnrbm.com/content/6/1/10
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control)/(cpm positive control - cpm negative control) ×
100). Each sample was analyzed in duplicates. Sera from
APS I, II and Addison patients known to have antibodies
against each antigen were used as positive controls and
one of the blood donors was used as a negative control in
each microwell plate. The upper normal limit of each anti-
body index, which was the mean value for 28 blood
donors plus 3 standard deviations, was calculated. Sera
from 40 additional blood donors were also used as blind
negative controls.
In addition 91 of the Turner patient sera were screened for
autoantibodies against thyroxin peroxidase (TPO) using
routine methods at the Div. of Clinical immunology,
Karolinska Hospital, Stockholm, Sweden.
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